Intravenous immunoglobulins for pemphigus vulgaris: adjuvant or first choice therapy?
- 1 June 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 138 (6) , 1102-1103
- https://doi.org/10.1046/j.1365-2133.1998.02297.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Successful treatment of refactory mucosal lesions of pemphigus vulgaris using intravenous gammaglobulin as adjuvant therapy.British Journal of Dermatology, 1996
- Successful treatment of pemphigus vulgaris by pulsed intravenous immunoglobulin therapyBritish Journal of Dermatology, 1996
- Intravenous immunoglobulin therapy: Modification of the immunofluorescence pattern in the skin of six patients with systemic lupus erythematosusArthritis & Rheumatism, 1996
- High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgarisBritish Journal of Dermatology, 1995
- Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patientsBritish Journal of Dermatology, 1995
- Effects of intravenous γ-globulin in pemphigusJournal of the American Academy of Dermatology, 1990
- High-dosage intravenous gamma globulin: Therapeutic failure in pemphigus and pemphigoidJournal of the American Academy of Dermatology, 1989
- Bullous Pemphigoid and Intravenous GammaglobulinAnnals of Internal Medicine, 1985